[47,48,49] |
MRI |
Used to elucidate the dimensions, quantity, chronology, and evolution of lesions in the CNS |
Central Nervous System (CNS) |
[50] |
MIP-1a |
Cytokine biomarker indicative of T cell activity |
Cerebrospinal Fluid (CSF) |
[50] |
CXCL10 |
Cytokine biomarker indicative of T cell activity |
Cerebrospinal Fluid (CSF) |
[50] |
CXCL13 |
Chemokine targeting B lymphocytes |
Not Specified |
[51,52,53,54,55] |
IgG Oligoclonal Bands (OCBs) |
Indicator of adaptive immunity activation in the CNS |
Cerebrospinal Fluid (CSF) |
[56,57,58,59] |
sNfL (serum neurofilament light chain) |
Potential prognostic and treatment response biomarker |
Blood Serum |